Q BioMed Inc. (QBIO)
OTCMKTS: QBIO · Delayed Price · USD
0.0003
0.00 (0.00%)
Mar 21, 2024, 12:06 PM EDT - Market closed

Q BioMed Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.
Year 202220212020201920182017201620152014
Net Income
-0.72-8.75-13.79-11.74-9.27-14.54-7.17-1.09-0.04
Depreciation & Amortization
0.050.050.050.0500000
Share-Based Compensation
0.92.346.572.500000
Other Operating Activities
1.72.060.935.092.828.965.6310
Operating Cash Flow
1.94-4.3-6.23-4.11-6.45-5.58-1.55-0.09-0.04
Capital Expenditures
0000-0.50000
Change in Investments
-3.14--------
Investing Cash Flow
-3.14000-0.50000
Dividends Paid
-0.97-0.5-0.38000000
Common Stock Issued
0.11.010.320.624.952.370.240.20.03
Share Repurchases
-0.650.5-1.97000.490.160.550
Other Financing Activities
1.124.464.330.973.873.062.810.56-
Financing Cash Flow
0.914.476.241.598.814.942.880.210.03
Net Cash Flow
-0.290.170-2.511.86-0.641.340.12-0.01
Free Cash Flow
1.94-4.3-6.23-4.11-6.95-5.58-1.55-0.09-0.04
Free Cash Flow Margin
682.75%-2199.44%-20778.14%------
Free Cash Flow Per Share
0.04-0.16-0.28-0.27-0.51-0.53-0.17-0.01-0.01
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.